CD36 is known as a fatty acid translocase associated with enhancing hepatic fatty acid uptake and then causes toxicity, inflammation, and apoptosis in hepatocytes; therefore, driving the development of NAFLD [69,70]. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.